Selective inhibitors of human corticosteroid synthases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9271963
APP PUB NO 20090221591A1
SERIAL NO

11885605

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to compounds for selectively inhibiting human corticosteroid synthases CYP1 1 B1 and CYP1 1 B2, and to the production and use thereof for treating hypercortisolism, diabetes mellitus, hyperaldosteronism, cardiac insufficiency, myocardial fibrosis, depression, age-related cognitive decline and metabolic syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT DES SAARLANDES66123 SAARBRÜCKEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hartmann, Rolf Saarbrücken, DE 34 365
Müller-Vieira, Ursula Saarbrücken, DE 1 77
Voets, Marieke Herent, BE 1 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00